Wolfgang Schüler
12Patents
5h-index
11Co-inventors
59Inventor score
Filing activity: Jan 9, 2015 → May 15, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9975927B2 | Mutant fragments of OspA and methods and uses relating thereto | Emerging Cross-Sectional Technologies | 8 | Active |
| US9926343B2 | Mutant fragments of OspA and methods and uses relating thereto | Emerging Cross-Sectional Technologies | 8 | Active |
| US10544194B2 | Mutant fragments of OspA and methods and uses relating thereto | Emerging Cross-Sectional Technologies | 7 | Active |
| US10766931B2 | Mutant fragments of OspA and methods and uses relating thereto | Emerging Cross-Sectional Technologies | 6 | Active |
| US11208439B2 | Mutant fragments of OspA and methods and uses relating thereto | Emerging Cross-Sectional Technologies | 5 | Active |
| US11466058B2 | Mutant fragments of OspA and methods and uses relating thereto | Emerging Cross-Sectional Technologies | 3 | Active |
| US11572392B2 | Mutant fragments of OspA and methods and uses relating thereto | Emerging Cross-Sectional Technologies | 3 | Active |
| US12018054B2 | Multivalent OspA polypeptides and methods and uses relating thereto | Emerging Cross-Sectional Technologies | 2 | Active |
| US12162909B2 | Subunit vaccine for treatment or prevention of a respiratory tract infection | Chemistry; Metallurgy | 0 | Active |
| US12195501B2 | Mutant fragments of OspA and methods and uses relating thereto | Emerging Cross-Sectional Technologies | 0 | Active |
| US12162907B2 | Subunit vaccine for treatment or prevention of a respiratory tract infection | Chemistry; Metallurgy | 0 | Active |
| US12331084B2 | Multivalent OspA polypeptides and methods and uses relating thereto | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.